German Cycling Athlete, Klier, Accepts Sanction For Anti-Doping Rule Violation

View PDF

August 15, 2013

USADA announced today that Andreas Klier, of Munich, Germany, a former athlete and current pro-cycling team director, has accepted a six-month suspension and loss of results for his use of prohibited substances during portions of his cycling career.

Klier, 37, admitted using prohibited substances including erythropoietin (EPO), human growth hormone and cortisone, as well as the use of the prohibited method of blood transfusion, from 1999-2006. The use of these prohibited substances and methods is prohibited under the Bund Deutscher Radfahrer (BDR) and the International Cycling Union (UCI) Anti-Doping Rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.

“We are thankful for the assistance in this case provided by our international partners at the German National Anti-Doping Agency and appreciate Mr. Klier’s willingness to provide full and truthful testimony about the culture of drug use in cycling,” said USADA CEO Travis T. Tygart. “We know that there are still many others in the sport, like Mr. Klier, who have important information to share about how the dangerous use of performance-enhancing drugs and methods took over the sport and was allowed to flourish. Our investigation into the sport of cycling is ongoing, and we will continue to fight for the rights of all athletes who want to have the full truth revealed so that the sport can finally move forward toward a truly clean future.”

Klier received a six-month period of ineligibility in accordance with the Code, for being forthcoming and providing full and true substantial assistance. His period of ineligibility began on August 12, 2013, and Klier has also been disqualified from all competitive results achieved on and subsequent to July 21, 2005, including forfeiture of any medals, points, and prizes.

In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.

USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.

─ # ─

CONTACT:
Media Relations
Phone: (719) 785-2000
E-mail:  media@usada.org